Out of the Lab, Into the Factory: Providing Cancer Immunotherapy to the Masses
December 8, 2021

At Umoja, we know that a cancer immunotherapy is only as good as the patients it reaches. We can do the best, most innovative, most exciting science at the bench, but if the manufacturing process is not scalable, the effort…


Looking Back, Looking Ahead: A Letter from Umoja’s CEO
October 6, 2021

Looking back over the past year, it is gratifying as CEO to reflect on the extraordinary progress we’ve made at Umoja Biopharma.   This year has had no shortage of major accomplishments for the company. Topping the list is our…